An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects

BACKGROUND: Despite multiple antidepressant options, major depressive disorder (MDD) still faces high non-response rates, eventually requiring anticonvulsant augmentation strategies too. The aim of this study was to explore such a potential role for zonisamide. METHODS: A total of 40 MDD outpatients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornaro, Michele, Martino, Matteo, Dalmasso, Bruna, Colicchio, Salvatore, Benvenuti, Marzia, Rocchi, Giulio, Escelsior, Andrea, Perugi, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184102/
https://www.ncbi.nlm.nih.gov/pubmed/21929762
http://dx.doi.org/10.1186/1744-859X-10-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184102/
https://www.ncbi.nlm.nih.gov/pubmed/21929762
http://dx.doi.org/10.1186/1744-859X-10-23

Ejemplares similares